1 |
OGURTSOVA K, ROCHA FERNANDES J D DA, HUANG Y, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040 [J]. Diabetes Res Clin Pract, 2017, 128: 40-50.
|
2 |
杨燕卓, 申红霞,韩瑞敏,等. 新型降糖药物治疗2型糖尿病的研究进展 [J]. 实用医学杂志, 2023, 39(2): 153-157.
|
3 |
ROBINSON R, BARATHI V A, CHAURASIA S S, et al. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals [J]. Dis Model Mech, 2012, 5(4): 444-456.
|
4 |
IBRAHIM A S, EL-REMESSY A B, MATRAGOON S, et al. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes [J]. Diabetes, 2011, 60(4): 1122-1133.
|
5 |
COUGHLIN B A, FEENSTRA D J, MOHR S. Müller cells and diabetic retinopathy [J]. Vision Res, 2017, 139: 93-100.
|
6 |
STEINLE J J. Role of HMGB1 signaling in the inflammatory process in diabetic retinopathy [J]. Cell Signal, 2020, 73: 109687.
|
7 |
中华医学会眼科学分会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年) [J]. 中华眼科杂志, 2014, 50(11): 851-865.
|
8 |
GORDON S, TAYLOR P R. Monocyte and macrophage heterogeneity [J]. Nat Rev Immunol, 2005, 5(12): 953-964.
|
9 |
FADINI G P, DE KREUTZENBERG S V, BOSCARO E, et al. An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy [J]. Diabetologia, 2013, 56(8): 1856-1866.
|
10 |
WAN H, CAI Y, WANG Y, et al. The unique association between the level of peripheral blood monocytes and the prevalence of diabetic retinopathy: a cross-sectional study [J]. J Transl Med, 2020, 18(1): 248.
|
11 |
ZENG C, SHI X, ZHANG B, et al. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications [J]. J Mol Med (Berl), 2012, 90(2): 175-186.
|
12 |
ABDEL-MONEIM A, BAKERY H H, ALLAM G. The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus [J]. Biomed Pharmacother, 2018, 101: 287-292.
|
13 |
LIU S, LIN Y U, LIU X. Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression [J]. Exp Ther Med, 2016, 11(1): 257-262.
|
14 |
DELIYANTI D, FIGGETT W A, GEBHARDT T, et al. CD8(+) T Cells Promote Pathological Angiogenesis in Ocular Neovascular Disease [J]. Arterioscler Thromb Vasc Biol, 2023, 43(4): 522-536.
|
15 |
MENART-HOUTERMANS B, TTER R R, NOWOTNY B, et al. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS) [J]. Diabetes Care, 2014, 37(8): 2326-2333.
|
16 |
LV X, GAO Y, DONG T, et al. Role of Natural Killer T (NKT) Cells in Type II Diabetes-Induced Vascular Injuries [J]. Med Sci Monit, 2018, 24: 8322-8332.
|
17 |
GUO H, XU B, GAO L, et al. High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus [J]. Exp Biol Med (Maywood), 2012, 237(5): 556-562.
|
18 |
DENG C, XIANG Y, TAN T, et al. Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults [J]. Diabetes Care, 2016, 39(3): 434-40.
|
19 |
YU H, LIU B, WU G, et al. Dysregulation of circulating follicular helper T cells in type 2 diabetic patients with diabetic retinopathy [J]. Immunol Res, 2021, 69(2): 153-161.
|
20 |
LIU B, HU Y, WU Q, et al. Qualitative and Quantitative Analysis of B-Cell-Produced Antibodies in Vitreous Humor of Type 2 Diabetic Patients with Diabetic Retinopathy [J]. J Diabetes Res, 2020, 2020: 4631290.
|
21 |
WANG C, YOU Q, CAO X, et al. Micro RNA-19a suppresses interleukin-10 in peripheral B cells of patients with diabetic retinopathy [J]. Am J Transl Res, 2017, 9(3): 1410-1417.
|